Virinchi Limited , a leading technology solutions provider, has successfully executed the first phase of its Rs 56.00 crore fundraising initiative. The company has allotted 40 lakh convertible equity warrants to IT Peer Technologies LLC at Rs 28.00 per warrant, following regulatory approvals and shareholder consent.

Warrant Allotment Details

The Stakeholders Relationship Committee approved the allotment on January 07, 2026, following in-principle approvals from both BSE and NSE received on December 31, 2025. The allotment represents the first tranche of the company's broader fundraising plan.

Complete Fundraising Framework

The overall fundraising plan, approved by shareholders at the Extraordinary General Meeting held on November 15, 2025, encompasses a larger scope:

Impact on Shareholding Structure

The current allotment has modified the company's shareholding pattern, with further changes expected upon full conversion:

Conversion Terms and Timeline

The warrants carry specific conversion provisions designed to provide flexibility to warrant holders:

• Conversion Ratio: Each warrant convertible into 1 equity share
• Exercise Period: Within 18 months from allotment date
• Payment Structure: 25% paid upfront (Rs 7.00 per warrant), balance 75% (Rs 21.00 per warrant) upon conversion
• Flexibility: Rights exercisable in one or more tranches
• Forfeiture Clause: Unexercised warrants will lapse after 18 months with forfeiture of paid amount

Regulatory Compliance and Next Steps

The allotment follows full regulatory compliance under SEBI (ICDR) Regulations, 2018, and SEBI Listing Regulations. The company received necessary approvals from both stock exchanges, confirming adherence to preferential issue norms.

The remaining portion of the fundraising plan involves allotment to promoter group entity Vivo Bio Tech Limited, which is expected to significantly increase promoter shareholding from the current 37.51% to 44.44% upon full conversion of all approved warrants.

This strategic fundraising initiative positions Virinchi to strengthen its financial foundation and support future growth initiatives in the technology solutions sector.

Virinchi Limited has announced a crucial board meeting scheduled for August 22, 2025, to deliberate on strategic business restructuring plans that could significantly impact the company's future direction.

Key Agenda Items

The board meeting, set to take place at the company's registered office, will focus on two major strategic initiatives:

1. SaaS Business Restructuring: The company is considering restructuring its Software as a Service (SaaS) business into a wholly-owned subsidiary through a slump sale. This move is aimed at creating a focused SaaS entity and potentially unlocking long-term shareholder value.

2. Partial Divestment and Fund Allocation: Virinchi is exploring options to divest a portion of its SaaS business. The company is considering various avenues for this divestment, including private investment, strategic partnerships, or an Initial Public Offering (IPO).

Strategic Objectives

The proposed restructuring and divestment plans are designed to achieve multiple strategic objectives:

1. Debt Reduction: Proceeds from the potential divestment of the SaaS business are intended to be used for reducing debt at the consolidated level, which could improve the company's financial health.

2. Healthcare Expansion: Part of the funds raised through the divestment is planned to be invested in the oncology healthcare vertical. This investment aims to support the expansion of the Virinchi hospital chain, potentially strengthening the company's presence in the healthcare sector.

3. Focused Growth: By creating a separate entity for the SaaS business, Virinchi Limited appears to be positioning itself for more focused growth and potentially enhanced operational efficiency in both its technology and healthcare verticals.

Investor Implications

These strategic moves, if approved and implemented, could have significant implications for Virinchi's shareholders:

• The creation of a focused SaaS subsidiary might lead to better valuation and visibility for this business segment.
• Debt reduction could improve the company's financial ratios and potentially its market perception.
• Expansion in the healthcare sector might diversify revenue streams and create new growth opportunities.

Investors and market watchers will be keenly awaiting the outcomes of this board meeting, as the decisions made could shape Virinchi Limited's business structure and growth trajectory in the coming years.

The company has duly informed the stock exchanges about this upcoming board meeting, in compliance with regulatory requirements.

Note: This article is based on the company's official communication to stock exchanges. Investors are advised to consult financial experts before making any investment decisions.